These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32719484)

  • 1. Population genetic screening efficiently identifies carriers of autosomal dominant diseases.
    Grzymski JJ; Elhanan G; Morales Rosado JA; Smith E; Schlauch KA; Read R; Rowan C; Slotnick N; Dabe S; Metcalf WJ; Lipp B; Reed H; Sharma L; Levin E; Kao J; Rashkin M; Bowes J; Dunaway K; Slonim A; Washington N; Ferber M; Bolze A; Lu JT
    Nat Med; 2020 Aug; 26(8):1235-1239. PubMed ID: 32719484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History.
    Patel AP; Wang M; Fahed AC; Mason-Suares H; Brockman D; Pelletier R; Amr S; Machini K; Hawley M; Witkowski L; Koch C; Philippakis A; Cassa CA; Ellinor PT; Kathiresan S; Ng K; Lebo M; Khera AV
    JAMA Netw Open; 2020 Apr; 3(4):e203959. PubMed ID: 32347951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome Sequencing Identifies Carriers of the Autosomal Dominant Cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations.
    Samadder NJ; Gay E; Lindpere V; Bublitz ML; Bandel LA; Armasu SM; Vierkant RA; Ferber MJ; Klee EW; Larson NB; Kruisselbrink TM; Egan JB; Kemppainen JL; Bidwell JS; Anderson JL; McAllister TM; Walker TS; Kunze KL; Golafshar MA; Klint MA; Presutti RJ; Bobo WV; Sekulic A; Summer-Bolster JM; Willman CL; Lazaridis KN
    JCO Precis Oncol; 2024 Jul; 8():e2400106. PubMed ID: 39013133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aligning policy to promote cascade genetic screening for prevention and early diagnosis of heritable diseases.
    George R; Kovak K; Cox SL
    J Genet Couns; 2015 Jun; 24(3):388-99. PubMed ID: 25577298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
    Menko FH; Ter Stege JA; van der Kolk LE; Jeanson KN; Schats W; Moha DA; Bleiker EMA
    Fam Cancer; 2019 Jan; 18(1):127-135. PubMed ID: 29846880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic counselors' perspectives on population-based screening for BRCA-related hereditary breast and ovarian cancer and Lynch syndrome.
    De Simone LM; Arjunan A; Vogel Postula KJ; Maga T; Bucheit LA
    J Genet Couns; 2021 Feb; 30(1):158-169. PubMed ID: 32562467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Prostate Cancer Associated With Familial and Hereditary Cancer Syndromes.
    Beebe-Dimmer JL; Kapron AL; Fraser AM; Smith KR; Cooney KA
    J Clin Oncol; 2020 Jun; 38(16):1807-1813. PubMed ID: 32208047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of a genomic screening program for actionable genetic conditions.
    Buchanan AH; Lester Kirchner H; Schwartz MLB; Kelly MA; Schmidlen T; Jones LK; Hallquist MLG; Rocha H; Betts M; Schwiter R; Butry L; Lazzeri AL; Frisbie LR; Rahm AK; Hao J; Willard HF; Martin CL; Ledbetter DH; Williams MS; Sturm AC
    Genet Med; 2020 Nov; 22(11):1874-1882. PubMed ID: 32601386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based genetic testing for Women's cancer prevention.
    Evans O; Gaba F; Manchanda R
    Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():139-153. PubMed ID: 32245629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy.
    Dudley B; Karloski E; Monzon FA; Singhi AD; Lincoln SE; Bahary N; Brand RE
    Cancer; 2018 Apr; 124(8):1691-1700. PubMed ID: 29360161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
    Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
    Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility.
    Rowley SM; Mascarenhas L; Devereux L; Li N; Amarasinghe KC; Zethoven M; Lee JEA; Lewis A; Morgan JA; Limb S; Young MA; James PA; Trainer AH; Campbell IG
    Genet Med; 2019 Apr; 21(4):913-922. PubMed ID: 30254378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes.
    Nakonechny QB; Gilks CB
    Surg Pathol Clin; 2016 Jun; 9(2):189-99. PubMed ID: 27241103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
    Schofield L; Goldblatt J; Iacopetta B
    Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark.
    Yang S; Axilbund JE; O'Leary E; Michalski ST; Evans R; Lincoln SE; Esplin ED; Nussbaum RL
    Ann Surg Oncol; 2018 Oct; 25(10):2925-2931. PubMed ID: 29998407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes.
    Manchanda R; Burnell M; Gaba F; Desai R; Wardle J; Gessler S; Side L; Sanderson S; Loggenberg K; Brady AF; Dorkins H; Wallis Y; Chapman C; Jacobs C; Legood R; Beller U; Tomlinson I; Menon U; Jacobs I
    BJOG; 2020 Feb; 127(3):364-375. PubMed ID: 31507061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the uptake of predictive testing and colorectal screening in Lynch syndrome: a regional primary care survey.
    Barrow P; Green K; Clancy T; Lalloo F; Hill J; Evans DG
    Clin Genet; 2015 Jun; 87(6):517-24. PubMed ID: 25652327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients Tested at a Laboratory for Hereditary Cancer Syndromes Show an Overlap for Multiple Syndromes in Their Personal and Familial Cancer Histories.
    Saam J; Arnell C; Theisen A; Moyes K; Marino I; Roundy KM; Wenstrup RJ
    Oncology; 2015; 89(5):288-93. PubMed ID: 26315041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Singapore Cancer Network (SCAN) Guidelines for Referral for Genetic Evaluation of Common Hereditary Cancer Syndromes.
    Singapore Cancer Network (SCAN) Cancer Genetics Workgroup
    Ann Acad Med Singap; 2015 Oct; 44(10):492-510. PubMed ID: 26763067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.